Related Experiment Video
Updated: Jan 2, 2026
07:32
Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model
Published on: May 6, 2020
13.0K
[Osteoarthritis and geriatric syndromes]
A V Naumov1, N O Khovasova1, V I Moroz1
1Pirogov Russian National Research Medical University, Moscow, Russia.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|December 12, 2019
Summary
Frailty significantly impacts geriatric patients with osteoarthritis (OA), increasing mobility issues and dependence. Early identification and management of frailty are crucial for improving OA patient outcomes.
Area of Science:
- Geriatric Medicine
- Rheumatology
- Public Health
Background:
- Osteoarthritis (OA) is a prevalent condition in older adults.
- Frailty is increasingly recognized as a significant factor affecting health outcomes in elderly populations.
Purpose of the Study:
- To investigate the geriatric status of osteoarthritis patients over 60.
- To analyze the impact of frailty severity on OA patients' health and functional status.
Main Methods:
- Included 201 osteoarthritis patients (mean age 75.84±8.09).
- Classified patients into three groups: no frailty, prefrailty, and frailty.
- Assessed clinical status, fall risk, pain intensity, Charlson Comorbidity Index, and geriatric syndromes.
Main Results:
- Increased frailty correlates with greater mobility difficulties and reduced physical activity.
- Prevalence of prefrailty and frailty in OA patients leads to increased dependence, decreased IADL, and slower walking speed.
- Common geriatric syndromes include sensory deficits, chronic pain, and falls; neuropathic pain component rises with frailty.
Conclusions:
- Frailty is a critical determinant of functional decline and geriatric syndromes in OA patients.
- The study highlights the need for tailored treatment recommendations considering frailty severity.
- Addressing frailty is essential for comprehensive OA management in the elderly.
Related Concept Videos
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
157
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
157
01:29Bone Disorders
5.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K
01:19The Effect of Aging on Tissues
3.1K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.1K
01:15Drug Dosing: Geriatric Patients
187
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
187
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
154
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
154
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
168
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
168